Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




MALDI-TOF MS Employed for Early Diagnosis of Bloodstream Infections

By LabMedica International staff writers
Posted on 17 Dec 2020
Bloodstream infections (BSIs) are a major cause of mortality in hospitalized patients. More...
Rapid diagnosis is crucial because any delay in the antimicrobial treatment is associated with an increase in adverse patient outcomes.

The routine identification of microorganisms in clinical microbiology laboratories is carried out by applying different tests, such as phenotypic essays based on microscopic, macroscopic, and biochemical analyses that allow determining their metabolic requirements, either manually or by automated systems.

A team of Medical Microbiologists at the Pontificia Universidad Javeriana (Bogotá, Colombia) analyzed 470 positive blood cultures from 190 patients’ samples using Standard Aerobic/F and Anaerobic/F blood culture media. Isolates were identified using conventional identification methods and by the direct method using the matrix-assisted laser desorption ionization-time of flight (MALDI-TOF MS) system.

All blood cultures were incubated in the BacT/ALERT blood culture system (bioMérieux, Marcy-L’Etoile, France). All isolates were identified using both conventional methods MicroScan WalkAway 96 Plus (Beckman Coulter, Brea, CA, USA), and MALDI-TOF MS.

The protein mass spectra were analyzed using the Flex Control software and the MALDI Biotyper version 3.1 7311 reference spectra (main spectra) (Bruker Daltonics, Bremen, Germany).

The team reported that in 470 blood cultures, the direct method showed good identification results (420/470, 89%); specifically, accurate species and genus identification in 283/470 (60%), and only correct genus identification in 137/470 (29%). The direct protocol had better performance for Gram-negative compared to Gram-positive bacteria (97% versus 76%) and was unable to identify the positive blood cultures for both yeasts and some bacteria, mostly Gram-positive (50/470).

The direct method was unable to identify the positive blood cultures for yeasts and for some bacteria such as Staphylococcus aureus 15/52, coagulase negative staphylococci 11/33, Salmonella spp. 3/3, Streptococcus salivarus 2/2, Actinomyces naeslundii 1/1, and Cutibacterium acnes 1/1. However, all strains of Staphylococcus aureus or coagulase negative staphylococci were identified through the conventional method.

The authors concluded that accurate identification of the pathogen species that cause an infection is paramount. Their study provided a rapid and easy method for the direct identification of pathogens from positive blood cultures. The in-house protocol used gave good and reliable results for Gram-negative bacteria and may be helpful for the identification of some Gram-positive bacteria. This allowed better use of the robust MALDI-TOF technology with results available up to 24 hours earlier, which could positively impact the treatment of patients. The study was published on December 1, 2020 in the International Journal of Infectious Diseases.

Related Links:
Pontificia Universidad Javeriana
bioMérieux
Beckman Coulter
Bruker Daltonics



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Candida Glabrata Test
ELIchrom Glabrata
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.